Testing effectiveness (Phase 2)UnknownNCT01688700
What this trial is testing
Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma
Who this might be right for
Esophageal Squamous Cell Carcinoma Resectable
Zhejiang Cancer Hospital 60